American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)

Azathioprine versus Mycophenolate Mofetil, Comparing Effectiveness for Treatment of Generalized Myasthenia Gravis

AANEM Guideline on Diagnostic and Screening Tests for Small Fiber Neuropathy

Ultrasound-Guided Nerve Hydrodissection for Peripheral Entrapment Neuropathies

Webinar: Approach to Immunization in Neuromuscular Disorders

AANEM Podcast Featuring ANF: Too Young for ALS? Mikey Stone’s Story and the EMG That Changed Everything

Lessons From the Lab: A patient with hand weakness–is a good clinical examination all that you need?

Multisystem Proteinopathies

Lessons From the Lab: A Patient With Fasciculations Here, There, EVERYWHERE!

The Impact of Hormonal Changes During Perimenopause on the Neuromusculoskeletal System - Part 2

The Impact of Hormonal Changes During Perimenopause on the Neuromusculoskeletal System - Part 1

Monoclonal Gammopathy Associated Myopathies

AANEM Crossfire Podcast: Should Neuromuscular Ultrasound be Routinely Used in the Diagnosis of CIDP?

Lessons From the Lab: Pediatric EMG Pearls on an Unusual Pediatric Case

AANEM Crossfire Podcast: Should Serum Neurofilament Light Chain or NfL be Incorporated into Routine ALS Clinical Practice?

AANEM Crossfire Podcast: Should a Combined Sensory Index be Used in Every Case of Suspected Carpal Tunnel Syndrome?

Lessons From the Lab: A Numb Foot Could be a Numb-er of Things

AANEM Crossfire Podcast: The Balance Between Diagnostic Testing and Clinical Care

Lessons From the Lab: LIVE at AANEM – A lively discussion about a strange arm problem.

Lessons From the Lab: A woman with shoulder weakness – just a rotator cuff problem?

Lessons Learned in the EMG Lab: Elevating EMG Practice Through International Exchange

Updates on Neuralgic Amyotrophy

Electromyography Referrals Principles and Practices for Optimizing EMG Orders

Evolving Therapeutic Horizons in Myasthenia Gravis: Expert Perspectives on Targeted Therapies: Part 2

Evolving Therapeutic Horizons in Myasthenia Gravis: Expert Perspectives on Targeted Therapies - Part 1